Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57B16 and ICR mice
- 31 May 1992
- journal article
- research article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 114 (1), 1-8
- https://doi.org/10.1016/0041-008x(92)90089-b
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cyclophosphamide ToxicityDrugs, 1991
- Metabolism and pulmonary toxicity of cyclophosphamidePharmacology & Therapeutics, 1990
- Systematically applied chemicals that damage lung tissueToxicology, 1985
- Pulmonary toxicity of cyclophosphamide: A 1-year studyExperimental and Molecular Pathology, 1985
- Increased Pulmonary Collagen Synthesis in Mice Treated with CyclophosphamideDrug and Chemical Toxicology, 1985
- Collagen production rates following acute lung damage induced by butylated hydroxytolueneBiochemical Pharmacology, 1982
- Cyclophosphamide cystitis—Identification of acrolein as the causative agentBiochemical Pharmacology, 1979
- Observations on the metabolism of cyclophosphamideBiochemical Pharmacology, 1972
- Metabolism of radioactive cyclophosphamide.Animal tests and clinical studiesCancer, 1967
- Metabolism of cyclophosphamideCancer, 1967